YS Biopharma (YS) Institutional Ownership → The Gold Grab of the Century (From Colonial Metals) (Ad) Free YS Stock Alerts $0.78 +0.01 (+1.30%) (As of 05/7/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for YS Biopharma (NASDAQ:YS)CurrentInstitutional OwnershipPercentage52.64%Number ofInstitutional Buyers(last 12 months)8TotalInstitutional Inflows(last 12 months)$11.92MNumber ofInstitutional Sellers(last 12 months)0 Get YS Insider Trade Alerts Want to know when executives and insiders are buying or selling YS Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data YS Institutional Buying and Selling by Quarter Ad Paradigm PressAI “wealth window” is closing June 25thToday, I’m making my boldest prediction ever. Next-generation AI technology will create the first $100 TRILLION industry.I put together this personal video [HERE]… YS Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/14/2024Superstring Capital Management LP307,920$166K0.1%N/A0.331% 9/21/2023Barclays PLC108,894$150K0.0%N/A0.423% 8/14/2023Prelude Capital Management LLC32,200$44K0.0%N/A0.125% 5/16/2023 Snow Lake Management LP1,811,942$2.90M1.7%N/A7.037% 5/16/2023Hhlr Advisors LTD.751,790$1.20M0.0%N/A2.920% 5/15/2023RTW Investments LP341,090$546K0.0%N/A1.325% 5/11/2023FIL Ltd2,718,499$4.35M0.0%N/A10.557% 5/10/2023Valliance Asset Management Ltd1,607,175$2.57M4.6%N/A6.241% (Data available from 1/1/2016 forward) YS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of YS shares? During the previous two years, the following institutional investors and hedge funds held shares of YS Biopharma shares: FIL Ltd ($4.35M), Snow Lake Management LP ($2.90M), Valliance Asset Management Ltd ($2.57M), Hhlr Advisors LTD. ($1.20M), RTW Investments LP ($546K), Superstring Capital Management LP ($166K), and Barclays PLC ($150K).Learn more on YS's institutional investors. What percentage of YS Biopharma stock is owned by institutional investors? 52.64% of YS Biopharma stock is owned by institutional investors. Learn more on YS's institutional investor holdings. Which institutional investors have been buying YS Biopharma stock? The following institutional investors have purchased YS Biopharma stock in the last 24 months: FIL Ltd ($2.72M), Snow Lake Management LP ($1.81M), Valliance Asset Management Ltd ($1.61M), Hhlr Advisors LTD. ($751.79K), RTW Investments LP ($341.09K), Superstring Capital Management LP ($307.92K), and Barclays PLC ($108.89K). How much institutional buying is happening at YS Biopharma? Institutional investors have bought a total of 7,679,510 shares in the last 24 months. This purchase volume represents approximately $11.92M in transactions. Related Companies: Rallybio Institutional Ownership Landos Biopharma Institutional Ownership MediciNova Institutional Ownership SCYNEXIS Institutional Ownership Viveon Health Acquisition Institutional Ownership Carisma Therapeutics Institutional Ownership vTv Therapeutics Institutional Ownership Assembly Biosciences Institutional Ownership Aileron Therapeutics Institutional Ownership CalciMedica Institutional Ownership This page (NASDAQ:YS) was last updated on 5/7/2024 by MarketBeat.com Staff From Our PartnersThe A.I. story nobody is telling you (Read ASAP)TradeSmithConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldElon Musk Secret Crypto Plot ExposedCrypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsObama’s Forever Term [exposed]Porter & CompanyPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyThe ONE AI Stock to own now. (It’s not Nvidia.)Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding YS Biopharma Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.